Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-11-16
MDCOMedicines Co /deCox Christopher TEVP, Chief Corp. Dev. OfficerP - Purchase$19.73+50,300281,763+22%+$992,419
2018-11-16
SIGASiga Technologies IncSavas Paul GDirP - Purchase$5.58+5,000237,847+2%+$27,900
DM
2018-11-14
TXMDTherapeuticsmd, Inc.Milligan John C.K. IVPres, SecretaryS - Sale+OE$4.90-258,0005,464,606-5%-$1,265,232
D
2018-11-16
JNJJohnson & JohnsonGorsky AlexCOB, CEOS - Sale+OE$145.96-264,465338,128-44%-$38,600,968
2018-11-14
RTRXRetrophin, Inc.McFarlane Neil F.COOS - Sale$23.73-10,00028,476-26%-$237,314
M
2018-11-14
RTRXRetrophin, Inc.Reed Elizabeth ESVP, GC, Corporate SecretaryS - Sale$24.03-5,00017,827-22%-$120,146
M
2018-11-14
RTRXRetrophin, Inc.Rote William E.SVP, R, DS - Sale$24.03-5,00017,992-22%-$120,130
M
2018-11-14
RTRXRetrophin, Inc.Clague LauraCFOS - Sale$24.02-7,50012,033-38%-$180,138
D
2018-11-15
GTHXG1 Therapeutics, Inc.Phillips Barclay ASVP, CFOS - Sale+OE$39.92-5,0000-100%-$199,591
M
2018-11-14
RTRXRetrophin, Inc.Aselage SteveCEOS - Sale$24.03-11,100253,283-4%-$266,703
D
2018-11-14
BMRNBiomarin Pharmaceutical IncAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale+OE$92.15-9,00049,135-15%-$829,359
DM
2018-11-14
EYEGEyegate Pharmaceuticals IncArmistice Capital, LLCDir, 10%P - Purchase$0.45+360,00034,325,000+1%+$161,395
D
2018-11-14
HZNPHorizon Pharma PlcWalbert Timothy PCOB, Pres, CEOS - Sale+OE$21.54-408,347546,070-43%-$8,795,794
DM
2018-11-15
ICPTIntercept Pharmaceuticals, Inc.Pruzanski MarkPres, CEOS - Sale+OE$101.07-50,000566,805-8%-$5,053,713
D
2018-11-15
FGENFibrogen IncRosenkranz Roberto PedroDirS - Sale+OE$39.24-1,00032,700-3%-$39,240
D
2018-11-15
FGENFibrogen IncKurkijarvi KaleviDirS - Sale+OE$39.77-4,00023,700-14%-$159,094
D
2018-11-16
CBIOCatalyst Biosciences, Inc.Levy HowardChief Medical OfficerS - Sale+OE$11.00-1737,560-2%-$1,903
D
2018-11-15
GTHXG1 Therapeutics, Inc.Velleca Mark A.Pres, CEOS - Sale+OE$39.84-5,00019,000-21%-$199,211
D
2018-11-15
GTHXG1 Therapeutics, Inc.Malik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$39.75-3,77614,700-20%-$150,105
2018-11-14
WVEWave Life Sciences Ltd.Verdine Gregory L.DirS - Sale$38.86-15,00060,039-20%-$582,849
2018-11-15
ICUIIcu Medical Inc/dePfizer IncDirS - Sale$209.25-2,500,0000-100%-$523,125,000
2018-11-14
CEMIChembio Diagnostics, Inc.Potthoff John GaryDirP - Purchase$5.81+20,00027,772+257%+$116,150
M
2018-11-14
AVEOAveo Pharmaceuticals IncEvnin Anthony BDirS - Sale$1.87-1,147,068418,414-73%-$2,140,527
D
2018-11-15
XOMAXoma CorpVan Ness W DenmanDirS - Sale+OE$12.67-5,5289,275-37%-$70,040
D
2018-11-15
CARACara Therapeutics, Inc.Mohindru ManiCFO, Chief Strategy OfficerS - Sale+OE$18.50-16,0420-100%-$296,777
2018-11-15
COLLCollegium Pharmaceutical, IncHeffernan Michael ThomasDirS - Sale$16.60-25,000336,000-7%-$415,122
2018-11-15
ENDPEndo International PlcHutson Nancy JDirS - Sale$12.83-10,00049,970-17%-$128,300
2018-11-15
KERXKeryx Biopharmaceuticals IncNeylan John F.Chief Medical OfficerS - Sale$2.77-1,156148,279-1%-$3,202
2018-11-15
KERXKeryx Biopharmaceuticals IncHolmes Scott ACFOS - Sale$2.77-1,155162,956-1%-$3,199
D
2018-11-15
ETONEton Pharmaceuticals, Inc.Casamento Charles JDirP - Purchase$6.00+5,00068,420+8%+$30,000
D
2018-11-14
AMPHAmphastar Pharmaceuticals, Inc.Zasloff Michael ADirS - Sale+OE$20.39-29,27829,845-50%-$596,949
D
2018-11-15
ETONEton Pharmaceuticals, Inc.Brynjelsen SeanPres, CEOP - Purchase$6.00+10,0001,034,940+1%+$60,000
D
2018-11-14
AMPHAmphastar Pharmaceuticals, Inc.Prins Richard KDirS - Sale+OE$20.23-5,00035,434-12%-$101,167
2018-11-14
AMPHAmphastar Pharmaceuticals, Inc.Shandell Jason B.Pres, GCS - Sale$20.41-16,015183,490-8%-$326,855
2018-11-15
ETONEton Pharmaceuticals, Inc.Maier Paul VDirP - Purchase$6.00+5,00059,745+9%+$30,000
2018-11-15
ETONEton Pharmaceuticals, Inc.Riedel Norbert GDirP - Purchase$6.00+5,00059,745+9%+$30,000
2018-11-15
ETONEton Pharmaceuticals, Inc.Troutman William WilsonCFO, Treasurer, SecretaryP - Purchase$6.00+5,0005,000New+$30,000
2018-11-15
ETONEton Pharmaceuticals, Inc.Baum Mark LDirP - Purchase$6.00+10,000794,745+1%+$60,000
2018-11-15
ACRXAcelrx Pharmaceuticals IncEdwards Mark GDirP - Purchase$2.82+20,700181,000+13%+$58,376
2018-11-13
ARDXArdelyx, Inc.Grammer Elizabeth AEVP, GCS - Sale$2.84-6,539135,204-5%-$18,571
2018-11-13
ARDXArdelyx, Inc.Raab MichaelPres, CEOS - Sale$2.84-6,539362,884-2%-$18,571
2018-11-13
ARDXArdelyx, Inc.Kaufmann MarkCFOS - Sale$2.84-6,539146,489-4%-$18,571
2018-11-13
ARDXArdelyx, Inc.Rosenbaum David P.Chief Development OfficerS - Sale$2.84-5,570262,034-2%-$15,819
DM
2018-11-13
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$3.85+31,31435,601,8000%+$120,578
2018-11-14
CNCEConcert Pharmaceuticals, Inc.Auchincloss Thomas GDirP - Purchase$11.93+1,0003,000+50%+$11,931
2018-11-15
CNCEConcert Pharmaceuticals, Inc.Aldrich RichardDirP - Purchase$11.83+50,000381,326+15%+$591,262
2018-11-13
ALBOAlbireo Pharma, Inc.Cooper Ronald Harold WilfredPres, CEOP - Purchase$25.02+1,0267,760+15%+$25,668
2018-11-13
XOMAXoma CorpNeal James RCEOP - Purchase$13.26+4,00023,294+21%+$53,056
D
2018-11-14
ATNXAthenex, Inc.Kwan RudolfEVP, Chief Medical OfficerP - Purchase$10.35+5,00097,224+5%+$51,748
DM
2018-11-13
PBHPrestige Consumer Healthcare Inc.Connors TimothyEVP, Sales, MarketingS - Sale+OE$38.96-74,70759,775-56%-$2,910,902
2018-11-13
RCUSArcus Biosciences, Inc.Jaen Juan C.PresP - Purchase$11.80+10,0002,943,6330%+$118,039
2018-11-12
PCRXPacira Pharmaceuticals, Inc.Wicki AndreasDirS - Sale$49.83-5,4781,036,377-1%-$272,980
2018-11-13
JAZZJazz Pharmaceuticals PlcMiller Michael PatrickEVP, US CommercialS - Sale$149.27-20024,972-1%-$29,854
DM
2018-11-12
TXMDTherapeuticsmd, Inc.Finizio Robert GCEOS - Sale+OE$4.77-184,00020,393,559-1%-$877,588
D
2018-11-14
ATNXAthenex, Inc.Lau Johnson Yiu NamCEO, COB, 10%P - Purchase$10.47+40,0003,835,130+1%+$418,800
D
2018-11-14
ATNXAthenex, Inc.Kwan RudolfEVP, Chief Medical OfficerP - Purchase$10.49+10,00092,224+12%+$104,900
D
2018-11-14
ATNXAthenex, Inc.Wu JinnDirP - Purchase$10.25+10,000321,208+3%+$102,500
D
2018-11-14
ATNXAthenex, Inc.Pedder SimonSee RemarksP - Purchase$10.26+2,9083,908+291%+$29,830
D
2018-11-12
AMRNAmarin Corp PlcukThero John FPres, CEOS - Sale+OE$19.07-607,6112,094,528-22%-$11,587,896
M
2018-11-09
CORTCorcept Therapeutics IncBaker G Leonard JrDirP - Purchase$12.95+200,0004,866,686+4%+$2,589,230
D
2018-11-14
ATNXAthenex, Inc.Yordon JeffreySee RemarksP - Purchase$10.49+9,500198,209+5%+$99,655
D
2018-11-14
ATNXAthenex, Inc.Sze RandollCFOP - Purchase$10.26+1,0001,000New+$10,255
M
2018-11-12
VRCAVerrica Pharmaceuticals Inc.Manning Paul BDir, 10%P - Purchase$14.15+70,2009,574,861+1%+$993,021
M
2018-11-09
ARPOAerpio Pharmaceuticals, Inc.Hoffman Stephen JCEOP - Purchase$2.01+31,96731,967New+$64,136
2018-11-12
NATRNatures Sunshine Products IncWynnefield Partners Small Cap Value LP10%P - Purchase$8.81+2,6442,205,0980%+$23,286
2018-11-13
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$113.41-2,460118,800,8040%-$278,979
2018-11-13
PRGOPerrigo Co PlcSamuels Theodore R. IIDirP - Purchase$65.40+3,50011,883+42%+$228,902
2018-11-09
IRWDIronwood Pharmaceuticals IncConsylman GinaCFOS - Sale$11.81-1,35896,361-1%-$16,038
M
2018-11-08
PCRXPacira Pharmaceuticals, Inc.Wicki AndreasDirS - Sale$51.11-58,2451,041,855-5%-$2,977,091
DM
2018-11-08
TXMDTherapeuticsmd, Inc.Bernick BrianDirS - Sale+OE$4.88-182,8006,802,371-3%-$891,333
M
2018-11-12
SIGASiga Technologies IncHruby Dennis EVP, Chief Scientific OfficerS - Sale$5.17-50,000197,465-20%-$258,263
2018-11-13
TCDATricida, Inc.Parker Geoffrey M.Chief Fin. Officer, SVPP - Purchase$29.72+5,00065,000+8%+$148,600
M
2018-11-09
ITCIIntra-Cellular Therapies, Inc.Marcus Joel SDirS - Sale$18.17-32,0001,291,569-2%-$581,580
M
2018-11-07
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.04+15,00026,147,4980%+$589
M
2018-11-08
AMPHAmphastar Pharmaceuticals, Inc.Zhou RongEVP, Production CenterS - Sale$20.50-2,173157,971-1%-$44,549
DM
2018-11-08
AMPHAmphastar Pharmaceuticals, Inc.Peters William JCFO, SVP, TreasurerS - Sale+OE$20.74-38,48478,152-33%-$797,972
DM
2018-11-08
AMPHAmphastar Pharmaceuticals, Inc.Liawatidewi YakobSVP Corp Admin CenterS - Sale+OE$20.97-17,80849,131-27%-$373,421
2018-11-12
SIGASiga Technologies IncGomez Phillip Louis IIICEOP - Purchase$5.20+15,00015,000New+$78,000
2018-11-12
ARDXArdelyx, Inc.Sandell Scott D10%S - Sale$2.98-59215,333,5820%-$1,767
M
2018-11-09
XBITXbiotech Inc.McKenzie W ThorpeDir, 10%P - Purchase$3.74+2,9003,513,0000%+$10,842
D
2018-11-12
ZTSZoetis Inc.Peck Kristin CEVPS - Sale+OE$94.78-11,50033,652-25%-$1,089,970
M
2018-11-09
INSMInsmed IncSharoky Melvin MdDirP - Purchase$16.01+20,000251,794+9%+$320,211
2018-11-09
BLCMBellicum Pharmaceuticals, IncStonehouse Jon PDirP - Purchase$4.56+10,00010,000New+$45,600
2018-11-13
ACRXAcelrx Pharmaceuticals IncAsadorian RaffiCFOP - Purchase$3.13+5,00047,000+12%+$15,646
M
2018-11-07
CKPTCheckpoint Therapeutics, Inc.Rosenwald Lindsay A MdDirP - Purchase$2.29+100,000126,448+378%+$229,211
2018-11-12
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$113.48-202,540118,803,2640%-$22,984,877
DM
2018-11-08
BGNEBeigene, Ltd.Peterson Amy C.CMO, Immuno-oncologyS - Sale+OE$120.20-40,000194,569-17%-$4,808,089
2018-11-09
FLXNFlexion Therapeutics IncClayman Michael D.Pres, CEOP - Purchase$17.10+5,000796,515+1%+$85,477
2018-11-09
FLXNFlexion Therapeutics IncArkowitz DavidCFOP - Purchase$16.56+4,00048,250+9%+$66,222
2018-11-09
LCILannett Co IncCrew Timothy CCEOP - Purchase$5.35+2,00041,988+5%+$10,700
2018-11-08
CTLTCatalent, Inc.Greisch John JDirP - Purchase$37.61+13,00018,376+242%+$488,930
D
2018-11-07
TXMDTherapeuticsmd, Inc.Cartwright Daniel ACFOS - Sale+OE$4.85-40,0000-100%-$194,000
2018-11-09
PRVBProvention Bio, Inc.Catlin Avery WDirP - Purchase$3.15+10,00010,000New+$31,500
2018-11-12
SIGASiga Technologies IncSavas Paul GDirP - Purchase$5.01+10,000232,847+4%+$50,100
2018-11-12
PRGOPerrigo Co PlcParker Geoffrey M.DirP - Purchase$65.35+3,0008,879+51%+$196,058
DM
2018-11-08
AMPHAmphastar Pharmaceuticals, Inc.Shandell Jason B.Pres, GCS - Sale+OE$20.77-52,296199,505-21%-$1,086,420
D
2018-11-09
RVNCRevance Therapeutics, Inc.Allouche CyrilPrincipal Accounting OfficerS - Sale+OE$23.72-2,1884,750-32%-$51,899
2018-11-09
ARWRArrowhead Pharmaceuticals, Inc.Anzalone Christopher RichardCEOS - Sale$14.39-81,5001,722,455-5%-$1,172,705
D
2018-11-08
SPPISpectrum Pharmaceuticals IncMaida Anthony E IIIDirS - Sale+OE$13.07-7,25032,988-18%-$94,758
D
2018-11-07
CCXIChemocentryx, Inc.Schall Thomas J.Pres, CEOS - Sale+OE$12.00-7,2112,184,9940%-$86,554
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top